Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, ROIVANT SCIENCES LTD. reported revenue of $8M, down 71.6% year over year. Operating margin was -6235.7% and net margin -3629.2%, on a free-cash-flow margin of -9183.5% with capital expenditure at 99.4% of revenue. Every figure is computed directly from ROIV's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $8M | -6235.7% | -3629.2% |
| FY2024 | $29M | -3453.3% | -592.0% |
| FY2023 | $33M | 13746.9% | 13294.2% |
| FY2022 | $32M | -2875.9% | -3200.2% |
| FY2021 | $55M | -2444.8% | -1528.9% |
How does ROIV compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.